American Society of Clinical Oncology

Until recently, no new drugs to treat children with cancer had been developed for several decades. This was because child cancer is rare and there was no incentive for big drug companies to spend money on producing new drugs specifically for cancer in children.


Syndicate content

Vist our Fundraising website